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ABSTRACT 
 
The regioselective reactions of fluorinated nitrones with selected terminal alkynes 
(Kinugasa reaction) was studied in the presence of Cu(I) iodide and TEA as a base. 
After chromatographic purification the desired β-lactams were obtained in high yields 
(up to 93%) and high diastereoselectivities (up to 9:1). The reactions performed in the 
presence of chiral, enantiomerically pure ligands led to enantiomerically enriched 
products (ee values up to 26%) obtained as one of the possible diastereoisomers 
depending on the type of chiral ligand used.  
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1.  Introduction 
 
In general, β-lactams are recognized as one of the most important classes  
of N-heterocycles with wide applications in medicine, biology and chemistry.1 In 
addition, fluorinated organic compounds attract attention as important components of 
drugs, agrochemicals, polymers and materials with special properties.2 Therefore, the 
development of methods for the synthesis of fluorinated β-lactams is a challenging 
task in modern organic synthesis.3 Currently, several methods for their preparation 
are known, and some representative examples for the synthesis of trifluoromethyl-
substituted β-lactams are presented in Fig. 1. The most important strategies are 
based on [2+2]-cycloadditions of fluorinated imines with differently substituted 
ketenes (Staudinger reaction),4 ester enolate/imine cyclo-condensation,5 and 
Reformatsky-type reactions.6 Other important approaches are intramolecular N-
acylation,7 intramolecular C-alkylation,8 and the ring expansion of 3-
(trifluoromethyl)aziridine-2-carboxylates.9 
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Figure 1. Some synthetic approaches to CF3-substituted β-lactams. 
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The Kinugasa reaction10 offers a general access to differently substituted  
β-lactams via the initial [3+2]-cycloaddition of the corresponding nitrones with 
terminal alkynes in the presence of a Cu(I) salt using a polar solvent (acetonitrile or 
formerly pyridine).11 The initial [3+2]-cycloaddition occurs regioselectively, and the 
asymmetric version of the Kinugasa reaction has also been developed successfully.12 
Very recently, Grée and co-workers reported the results of their study on the 
Kinugasa reaction with propargylic gem-difluorides in which mixtures of 3-
(difluoroalkyl) and/or 3-(1-fluoroalkylidene) β-lactams were obtained (Scheme 1).13 
 
 
 
Scheme 1. Kinugasa reaction with fluorinated acetylenes leading to mixtures of 
fluorinated β-lactams.13 
 
Due to our continuing interest in the development of methods for the 
preparation of fluorinated heterocycles, we present a new application of fluorinated 
nitrones for the preparation of fluroalkylated β-lactams via the Kinugasa reaction. In 
addition, the elaboration of an asymmetric version of the reaction was also of interest. 
For our studies, preparation of nitrones 2a–d,14a derived from fluoral and 
difluoroacetaldehyde, was performed based on modified literature procedures 
(Scheme 2).14b-d Instead of a one-pot procedure a protocol with isolation of the 
intermediate hemiaminal of type 1 in the case of CF3 derivatives was shown to be a 
more efficient one.  
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Scheme 2. Synthesis of fluorinated nitrones 2. 
 
2.  Results and discussion 
 
The isolated and purified nitrones 2a and 2c were used for the test reaction 
with phenylacetylene (3a) under the typical conditions for the Kinugasa reaction, i.e., 
using anhydrous MeCN, 0 ºC to room temperature, and CuI as a catalyst. Among 
several bases tested (TEA, dicyclohexylamine (Cy2NH), Cy2NMe, CyNMe2, DABCO 
and DBU), TEA proved to be the most suitable one. In the case of 2a, the crude 
reaction mixture was analyzed by 1H NMR spectroscopy, which showed the presence 
of two isomeric β-lactams in a ratio of ca. 4:1 (cis-4a, trans-4a, Scheme 3). These 
diastereoisomers were separated by means of flash-column chromatography. The 1H 
NMR spectrum of the major product (more polar fraction) showed a doublet at 4.64 
ppm with 3J(H,H) = 5.4 Hz attributed to HC(3) as well as a multiplet at 4.02–3.98 ppm 
for HC(4). The value of the coupling constant confirms the cis orientation of the H-
atoms.8,15 The corresponding coupling constant for the trans isomer was determined 
as 3JH,H = 2.4 Hz from the signal for HC(4), which appeared as a doublet × quartet at 
3.85 ppm. Based on these data, the structures of the expected diastereomeric β-
lactams cis- and trans-4a were confirmed (Scheme 3). In addition, the cis-
configuration of the major product cis-4a was unambiguously established by X-ray 
crystallography (Fig. 2). 
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Scheme 3. Kinugasa reaction with fluorinated nitrones 2 and acetylenes 3 leading  
to fluorinated β-lactams 4. 
 
 
 
Figure 2. ORTEP16 representation of the molecule cis-4a (arbitrary numbering  
of atoms, 50% probability ellipsoids; H-atoms given arbitrary displacement 
parameters). 
 
Table 1.  
Fluorinated β-lactams via Kinugasa reaction. 
 
Nitrone RF R1 Acetylene R2 β-
Lactam 
Total 
yielda) 
cis/trans Reaction 
time [h] 
2a CF3 Bn 3a Ph 4a 89 83/17c) 16 
2a CF3 Bn 3b CH(OEt)2 4b 68 71/29c) 16 
2a CF3 Bn 3c 4-F-C6H4 4c 90 30/70c) 36 
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2a CF3 Bn 3d CO2Me 4d 51b) 0/100c) 36 
2a CF3 Bn 3e t-Bu 4e 59 24/76c) 16 
2a CF3 Bn 3f Ferrocenyl 4f 70b) 10/90d) 16 
2a CF3 Bn 3g 
O
O Me
Me 	  
4g 82 41/50/9d)e) 36 
2b CF3 (S)-
Me(Ph)
CH 
3a Ph 4h 61 14/11/24/51d) 16 
2c CHF2 Bn 3a Ph 4i 93 70/30d) 16 
2d CHF2 (S)-
Me(Ph)
CH 
3a Ph 4j 58 9/18/73d) 16 
 
a) Total yield of pure mixture of diastereoisomers 
b) Isolated trans-isomer 
c) Calculated based on the amount of isolated pure isomers 
d) Determined by 1H NMR spectroscopy in the isolated pure mixture of 
diastereoisomers 
e) Only one isomer was isolated as a pure fraction (less polar) (see Experimental) 
 
The reaction of 2c and 3a under the same conditions also yielded a mixture of 
diastereoisomeric β-lactams, cis- and trans-4i (ca. 7:3), in 93% yield. However, in this 
case, attempted chromatographic separation of the isomers was unsuccessful. 
The analogous protocol was applied to reactions of 2a with acetylenes 3b-g, 
and in all cases, except with 3d (R = CO2Me), mixtures of the expected  
cis- and trans-β-lactams were obtained diastereoselectively. While in the case  
of 3b the major isomer was also identified as the cis-diastereoisomer, the trans-
isomer was found to be the predominant product of the reactions performed with 
ethynylferrocene (3f) as well as with 4-fluorophenyl- (3c), tert-butyl- (3e), and (R)-2,2-
dimethyl-1,3-dioxolan-4-yl- (3g) substituted acetylene. Furthermore, the reaction with 
methyl propiolate (3d) led to the trans-disubstituted β-lactam, trans-4d, exclusively. In 
the latter case, the diagnostic coupling constant 3J(HC(3),HC(4)) was 2.1 Hz.  
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While the cis- and trans-isomers of 4a–f and 4i were obtained as racemic 
materials, the products of the reaction of 2a with enantiopure 3g were optically active, 
formed in a diastereoselective manner. Thus, chromatographic workup of 4g led to 
two fractions. The less polar fraction consists of a pure diastereoisomer, but the more 
polar fraction was identified as a mixture of two other diastereoisomers. Based on the 
amounts of isolated fractions and the registered 1H and 19F NMR spectra, the ratio of 
these products was calculated to be 41/50/9 (Table 1). In analogy to 4a-e, the 
product in the less polar fraction was assigned as the trans-configured isomer ((S)-
trans-4g) and two other products, obtained in the more polar fraction, are postulated 
to display the cis-configuration within the β-lactam ring ((S)-cis-4g’ and (S)-cis-4g’’). 
Similarly, the reaction of nitrone 2b containing the (S)-methylbenzyl 
substituent as R1 with phenylacetylene (3a) under standard conditions led to a 
mixture of four optically active diastereoisomeric β-lactams (Figure 3) in a ratio of 
14/11/24/51 (Table 1). After chromatographic workup, three of these products were 
isolated as pure isomers. Two of them were identified as trans isomers ((S)-trans-4h 
(16%) and (S)-trans-4h’ (38%)) on the basis of the HC(3),HC(4) coupling constant 
(3J(H,H)) of 2.4 Hz in both cases. The corresponding coupling constant of the third 
product, isolated in 7% yield, was determined to be 3J(H,H) = 6.0 Hz, indicating the 
cis-configuration ((S)-cis-4h’’). 
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Figure 3. Diastereoisomeric β-lactams from the reaction of 2b with 3a. 
 
Finally, the chiral nitrone 2d reacted with 3a to give a mixture of three 
stereoisomeric β-lactams 4j (in ratio of 9/18/73) in 58% yield. In this case, attempted 
separation of the isomers was unsuccessful. 
The stepwise mechanism of the Kinugasa reaction has been proposed by 
many authors.11e,f The initial regioselective [3+2]-cycloaddition of the nitrone onto the 
C≡C bond is postulated to be followed by the ring contraction of the isoxazoline to 
give the four-membered azetidin-2-one ring. It seems likely that the cis-β-lactams 4a-
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d,g,i are formed as kinetically controlled products and in the case of 4c,d, containing 
an activated, acidic HC(3) moiety, undergoes fast isomerization to the 
thermodynamically more stable trans-products. On the other hand, in the case of 
derivatives bearing a bulky substituent at C(3)- or at the N-atom (i.e. in compounds 
4e,f,h,j), steric hindrance can govern the cycloaddition step in favour of the sterically 
less congested trans-β-lactams.  
The asymmetric Kinugasa reaction has been studied extensively, and ligands 
containing the bis-oxazoline motif as well as BINOL were applied successfully.11e,12,17 
In the present study, three bis-oxazoline ligands L1-L3 (Figure 4) were applied to 
induce the asymmetric course of the reaction of 2a with phenylacetylene (3a). In 
addition, two other ligands L4 and L5 were also tested. In experiments performed in 
the presence of L1-L4, the formation of only one diastereoisomer with complete 
diastereoselectivity was observed. However, while with L2, L3, and L4 
diastereoselective formation of trans-β-lactams was observed, the reaction 
performed in the presence of L1 gave the cis-configured product 4a exclusively. In 
contrast, reaction of 2a with 3a carried out in the presence of ligand L5 afforded a 
mixture of cis-4a and trans-4a in a ratio of 60/40 (Scheme 4). In the latter case, after 
preliminary purification, the ratio of the diastereoisomers cis/trans-4a was determined 
by 1H NMR spectroscopy. The ee values for the diastereoisomers were obtained 
from the HPLC analysis using a Phenomenex Lux Cellulose-1 chiral column. The 
determined ee values of the obtained products were generally low and in the best 
case, i.e. product trans-4a, obtained in the experiment with L4 as a ligand, was 
determined to be 26%. In order to check the reported, high enantioselectivities in the 
Kinugasa reaction with C-phenyl nitrones in the presence of the ligand L2,17a the 
reaction of C,N-diphenyl nitrone with 3a was repeated in our laboratory and the 
obtained results were consistent with the reported data (high diasteroselectivity (dr = 
93:7) and enantioselectivity (94%) for the major cis-isomer). For that reason, we 
postulate tentatively that the low enantioselectivity observed in the reaction with 
nitrone 2a may result from the presence of the CF3 group (instead of the Ph 
substituent), which does not coordinate efficiently enough with another Ph-ring of 3a 
as it was postulated in the stereochemical model of the Kinugasa reaction presented 
in literature for the C,N-diphenyl nitrone.11e,17b  
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Scheme 4. Asymmetric Kinugasa reaction of the fluorinated nitrone 2a with 
phenylacetylene (3a). 
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Figure 4. Chiral ligands applied in the asymmetric Kinugasa reaction. 
 
3.  Conclusions 
 
As there is growing interest in the synthesis of fluorinated β-lactams and their 
applications,18 a need for the elaboration of new methods for their synthesis is 
emerging and their development is a challenging task for the modern organic 
synthesis. The novel Kinugasa approach based on the application of relatively little 
known fluorinated nitrones is presented for the first time. Different mono-substituted 
acetylenes were shown to react with fluorinated nitrones under typical Kinugasa 
reaction conditions, and the expected 4-trifluoromethyl- and 4-difluoromethyl-β-
lactams were formed in good to high yields. The cis/trans-diastereoselectivity varied 
depending on the type of substituent on the acetylene used in the reaction. In the 
case of a chiral, enantiopure nitrone, mixtures of optically active diastereoisomers 
were formed. The attempted asymmetric Kinugasa reaction with phenylacetylene and 
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the achiral N-benzyl C-trifluoromethyl nitrone in the presence of a catalytic amount of 
different chiral ligands led to a remarkable increase in the diastereoselectivity, 
although the observed ee-values were low.  
The presented approach supplements a very recently reported protocol, in 
which fluorinated acetylenes were reacted with nitrones.13 However, in that case, 
mixtures of 3-fluoroalkylidene- and 3-difluoroalkyl-β-lactams were obtained. Thus, the 
β-lactams described in the present study differ from those reported.13 by the fact that 
the fluorinated alkyl group is located at C(4) exclusively. 
 
4.  Experimental section 
 
4.1.  General  
Melting points were determined on a Stuart SMP30 apparatus in capillaries. 
The 1H, 13C{1H}, and 19F NMR spectra were recorded on a Bruker Avance III (600, 
150 and 565 MHz, respectively), or in the case of 19F{1H} on a Bruker Avance III 200 
(188 MHz) spectrometer using the solvent signal as reference; chemical shifts (δ) in 
ppm and coupling constants J in Hz. Assignments of signals in 13C NMR spectra 
were achieved using HMQC and HMBC techniques. IR spectra were measured using 
a NEXUS FT-IR spectrophotometer. The ESI-HRMS spectra were recorded using a 
Waters GCT Premier High Resolution mass spectrometer or on a Bruker MAXIS 
spectrometer. Specific rotations ([α]D22) were measured on a PERKIN-ELMER 241 
MC polarimeter for λ = 589 nm, in dichloromethane at room temperature and their 
values are given in 10−1 deg cm2 g−1. 
All solvents were used as commercial products. Trifluoroacetaldehyde hydrate 
(75%) and difluoroacetaldehyde ethyl hemiacetal (95%) were purchased from 
FluoroChem. Anhydrous acetonitrile was purchased from Acros and was degassed 
before use. Nonchiral and chiral enantiomerically pure N-hydroxylamines were 
prepared according to the known literature protocols.19 
  
4.2. Synthesis of nitrones derived from fluoral and difluoroacetaldehyde.  
N-Benzyl-N-(2,2,2-trifluoro-1-hydroxyethyl)hydroxylamine (N-Benzyl C-
(trifluoromethyl)nitrone hydrate; 1a), N-Benzyl C-(trifluoromethyl)nitrone (2a), 
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and N-Benzyl C-(difluoromethyl)nitrone (2c) were prepared following the published 
protocol.14a  
N-(S)-Methylbenzyl-N-(2,2,2-trifluoro-1-hydroxyethyl)hydroxylamine (N-(S)-
Methylbenzyl-C-(trifluoromethyl)nitrone hydrate; 1b).  
Trifluoroacetaldehyde hydrate (75%) (1.08 g, 6.5 mmol) was added to a solution of 
freshly prepared N-(S)-(methylbenzyl)hydroxylamine (685 mg, 5.0 mmol) in 
dichloromethane (10 ml). The reaction was carried out at room temperature in the 
presence of activated molecular sieves 4 Å for 1 h. Then, an additional portion of 
drying agent (Na2SO4) was added. After filtration, the solvent was evaporated and 
crude hemiaminal was obtained in nearly quantitative yield (1.07 g) as a colorless 
liquid, and was used for the next step without purification. 
 
N-(S)-Methylbenzyl C-(trifluoromethyl)nitrone (2b).14d  
The crude hemiaminal described above was suspended in toluene (15 ml) and a 
catalytic amount of p-TsOH.H2O (19 mg, 0.1 mmol) was added. The mixture was 
heated at reflux in a Dean-Stark apparatus. After ca. 30 min, the water had been 
removed completely and the solvent was evaporated in vacuo. Pure product was 
obtained after purification by flash column chromatography (conditions: Grace 
Reveleris X2 apparatus with UV-Vis and ELSD detection, using commercially 
available SiO2 columns 12 g or 24 g, pressure 20 psi, solvent flow rate 25 ml/min) 
using petroleum ether with increasing amounts of ethyl acetate (up to 8:2) as eluent. 
  
Colorless solid nitrone 2b (879 mg, 81% yield, purification on SiO2, using petroleum 
ether/AcOEt = 90:10)); m.p. 111–113 ºC (petroleum ether/Et2O); [α]D22 = –20.0 (c 1.0 
in DCM); IR (KBr): vmax/cm–1 3096s, 3026w, 1591vs (HC=N), 1457s, 1247s, 1204vs, 
1152vs, 913s, 703s; 1H NMR (600 MHz, CDCl3), δ: 7.48–7.43 (m, 5 CHAr), 6.97 (q, 
3J(H,F) = 6.0 Hz, 1H, F3CCH=N), 5.16 (q, 3J(H,H) = 7.2 Hz, 1H, CH3(CH)Ph), 1.87 (d, 
3J(H,H) = 6.6 Hz, 3H, CH3(CH)Ph); 13C NMR (150 MHz, CDCl3), δ: 136.7 (1 CAr), 
129.5, 129.1, 127.3 (5 CHAr), 122.2 (q, 2J(C,F) = 41.1 Hz, F3CCH=N); 119.6 (q, 
1J(C,F) = 268.2 Hz, CF3), 76.4 (CH3(CH)Ph)), 18.4 (CH3(CH)Ph); 19F NMR (565 MHz, 
CDCl3), δ: –65.94 (d, 3J(F,H) = 5.1 Hz, 3F, CF3); HRMS/ESI (m/z) [M+Na]+ calcd for 
C10H10F3NONa, 240.0606, found 240.0607.  
 
	   12	  
N-(S)-Methylbenzyl C-(difluoromethyl)nitrone (2d).  
Difluoroacetaldehyde ethyl hemiacetal (95%) (897 mg, 6.5 mmol) was added to a 
solution of freshly prepared enantiomerically pure N-(S)-(methylbenzyl)hydroxylamine 
(685 mg, 5.0 mmol) and a catalytic amount of p-TsOH.H2O (19 mg, 0.1 mmol) in 
toluene (10 ml). The mixture was heated at reflux in a Dean-Stark apparatus until 
evolution of water was finished (ca. 30 min), and then the solvent was evaporated 
under reduced pressure. Analytically pure product was obtained after purification by 
flash column chromatography (conditions: Grace Reveleris X2 apparatus with UV-Vis 
and ELSD detection, using commercially available SiO2 columns, 12 g or 24 g, 
pressure 20 psi, solvent flow rate 25 ml/min) using petroleum ether with increasing 
amounts of ethyl acetate (up to 8:2) as eluent. 
 
Colorless solid nitrone 2d (796 mg, 80% yield, purification on SiO2, using petroleum 
ether/AcOEt = 90:10); m.p. 67–70 ºC (petroleum ether/Et2O); [α]D22 = –60.6 (c 1.0 in 
DCM); IR (KBr): vmax/cm–1 3166w, 3089s, 3033w, 1589vs (C=N), 1462s, 1290s, 
1112vs, 1049vs, 696vs; 1H NMR (600 MHz, CDCl3), δ: 7.48–7.46 (m, 2 CHAr), 7.43–
7.40 (m, 3 CHAr), 7.09–7.03 (m, 1H, (F2HCCH=N)), 6.68 (dt, 2J(H,F) = 53.4 Hz, 
3J(H,H) = 5.3 Hz, 1H, (F2HCCH=N), 5.11 (q, 3J(H,H) = 6.9 Hz, 1H, CH3(CH)Ph), 1.83 
(d, 2J(H,H) = 7.0 Hz, 3H, CH3(CH)Ph); 13C NMR (150 MHz, CDCl3), δ: 137.0 (1 CAr), 
128.3 (t, 2J(C,F) = 32.6 Hz, F2HCCH=N), 129.3, 129.0, 127.4 (5 CHAr), 108.9 (t, 
1J(C,F) = 231.0 Hz, F2HCCH=N), 75.1 (CH3(CH)Ph), 18.8 (CH3(CH)Ph); 19F NMR 
(565 MHz, CDCl3), δ: –121.46, –121.34 (2s, 2F, CHF2); HRMS/ESI (m/z) [M+Na]+ 
calcd for C10H11F2NONa, 222.0706, found 222.0704. 
 
4.3. General Procedure for the Preparation of β-Lactams 4 (Kinugasa 
Reaction). 
 
To an oven-dried flask, equipped with a septum, stirring bar and a balloon filled with 
argon was added CuI (190 mg, 1.0 mmol). Then, anhydrous and degassed 
acetonitrile (2 ml) was added. To the stirred suspension (ice bath), a mixture  
of the appropriate acetylene 3 (1.0 mmol) was added. After 5 min, a solution  
of dry triethylamine (TEA, 202 mg, 2.0 mmol) in anhydrous and degassed MeCN  
(3 ml) was added at 0 °C (ice bath) while stirring under an inert atmosphere,  
and after 10 min, a solution of a fluorinated nitrone 2 (2.0 mmol) in dry acetonitrile  
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(3 ml) was added. After another 10 min, the ice bath was removed and the reaction 
mixture was left at room temperature for 16 or 36 h. Then, dichloromethane (DCM,  
5 ml) was added and the solvents were removed under reduced pressure.  
Crude products were purified by flash column chromatography (conditions: Grace 
Reveleris X2 apparatus with UV-Vis and ELSD detection, using commercially 
available 12 g or 24 g SiO2 columns, pressure 20 psi, solvent flow rate 25 ml/min) 
using petroleum ether with increasing amounts of ethyl acetate (up to 7:3) as eluent. 
 
For the asymmetric version of the reaction, the appropriate chiral ligand L1-5  
(0.06 mmol) dissolved in dry acetonitrile (1 ml) was added to the stirred suspension 
of CuI (190 mg, 1.0 mmol) in anhydrous and degassed acetonitrile (2 ml),  
and the mixture was stirred at room temperature for 2 h. The solution was cooled  
to 0 °C and a solution of TEA (2.0 mmol) in dry MeCN was added. After 10 min, 
a solution of phenylacetylene (3a) was added, followed by nitrone 2a dissolved 
in anhydrous MeCN after 30 min. The ice bath was removed after 15 min,  
and the reaction mixture was left at room temperature for 16 h under inert 
atmosphere. Workup was carried out as described above. The diastereoselectivity 
was determined by analysis of the 1H NMR spectra obtained from the preliminarily 
purified product. Enantiomeric excess was determined using chiral HPLC 
with a Phenomenex Lux Cellulose-1 column. 
 
trans-N-Benzyl-3-phenyl-2-(trifluoromethyl)azetidin-2-one (trans-4a).  
Orange oily β-lactam trans-4a (45 mg, 15% yield, purification on SiO2, using 
petroleum ether/AcOEt = 95:5, less polar fraction); IR (film): vmax/cm–1 3091w, 3057w, 
3032w, 2931w, 1776vs (C=O), 1498s, 1453s, 1396s, 1281s; 1H NMR (600 MHz, 
CDCl3), δ: 7.43–7.33 (m, 8 CHAr), 7.26–7.25 (m, 2 CHAr), 5.01, 4.10 (AB system, 
2J(H,H) = 15.0 Hz, 2H, CH2Ph), 4.50 (brs, 1H, C(3)H), 3.85 (dq, 3J(H,H) = 2.4 Hz, 
3J(H,F) = 6.4 Hz, 1H, C(4)H); 13C NMR (150 MHz, CDCl3), δ: 166.5 (C=O), 134.7, 
132.7 (2 CAr), 129.2, 129.1, 128.6, 128.3, 128.2, 127.3 (10 CHAr), 124.4 (q, 1J(C,F) = 
278.3 Hz, CF3), 58.0 (q, 2J(C,F) = 33.8 Hz, C(4)H), 56.4 (C(3)H), 45.8 (CH2Ph); 19F 
NMR (565 MHz, CDCl3), δ: –73.69 (d, 3F, 3J(H,F) = 6.4 Hz, CF3); HRMS/ESI (m/z) 
[M+Na]+ calcd for C17H14F3NONa, 328.0919, found 328.0925; Racemic mixture: 
HPLC (Phenomenex Lux Cellulose-1 column, hexane/i-PrOH = 9:1, flow rate = 0.6 
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ml/min, λ = 210 nm, tR = 7.70 min (first enantiomer), tR = 8.73 min (second 
enantiomer). 
 
cis-N-Benzyl-3-phenyl-2-(trifluoromethyl)azetidin-2-one (cis-4a).  
Colorless semi-solid β-lactam cis-4a (226 mg, 74% yield, purification on SiO2, using 
petroleum ether/AcOEt = 90:10, more polar fraction); m.p. 102–103 ºC; IR (KBr): 
vmax/cm–1 3032 w, 2928w, 2854w, 1751vs (C=O), 1449w, 1371w, 1285s, 1130vs, 
698s; 1H NMR (600 MHz, CDCl3), δ: 7.32–7.21 (m, 10 CH(arom.)), 4.64 (d, 3J(H,H) = 
5.4 Hz, 1H, C(3)H), 4.02–3.98 (m, 1H, C(4)H), 3.97, 4.91 (AB system, 2d, 2J(H,H)= 
15.0 Hz, 2H, CH2Ph); 13C NMR (150 MHz, CDCl3), δ: 166.8 (C=O), 134.6, 130.2 (2 
CAr), 129.1 (brs, 2 CHAr), 129.0, 128.6, 128.5, 128.3 (8 CHAr), 123.8 (q, 1J(C,F) = 
278.9 Hz, CF3), 57.0 (C(3)H), 55.7 (q, 2J(C,F) = 31.5 Hz, C(4)H), 45.7 (CH2Ph); 19F 
NMR (565 MHz, CDCl3), δ: –68.80 (d, 3F, 3J(H,F) = 6.2 Hz, CF3); HRMS/ESI (m/z) 
[M+Na]+ calcd for C17H14F3NONa, 328.0919, found 328.0925; Racemic mixture: 
HPLC (Phenomenex Lux Cellulose-1 column, hexane/i-PrOH = 9:1, flow rate = 0.6 
ml/min, λ = 210 nm, tR = 5.24 min (first enantiomer), tR = 5.91 min (second 
enantiomer). 
 
trans-N-Benzyl-3-(diethoxymethyl)-2-(trifluoromethyl)azetidin-2-one (trans-4b). 
Pale yellow oily β-lactam trans-4b (65 mg, 20% yield, purification on SiO2, using 
petroleum ether/AcOEt = 95:5, less polar fraction); IR (KBr): vmax/cm–1 3035w, 2961s, 
2979s, 2929m, 2979m, 1779vs (C=O), 1401s, 1279vs, 1193vs, 1132vs, 1055vs, 
692s; 1H NMR (600 MHz, CDCl3), δ: 7.39–7.32 (m, 5 CHAr), 4.82 (d, 3J(H,H) = 2.4 Hz 
1H, CH(OEt)2), 4.05 (dq, 3J(H,H) = 1.8 Hz, 3J(H,F) = 5.4 Hz, 1H, C(4)H), 4.95, 3.96 
(AB system, 2d, 2J(H,H) = 15.6 Hz, 2H, CH2Ph), 3.57–3.55 (m, 1H, C(3)H), 3.82–
3.80, 3.68–3.58, 3.53–3.48 (3m, 4H, 2 CH3CH2O), 1.22–1.19 (m, 6H, 2 CH3CH2O); 
13C NMR (150 MHz, CDCl3), δ: 165.1 (C=O), 134.4 (1 CAr), 128.7, 128.4 127.9 (5 
CHAr), 124.5 (q, 1J(C,F) = 277.7 Hz, CF3), 98.4 (CH(OEt)2), 64.2, 63.3 (2 CH3CH2O), 
55.9 (C(3)H), 51.2 (q, 2J(C,F) = 34.3 Hz, C(4)H), 45.4 (CH2Ph), 15.0, 15.1 (2 
CH3CH2O); 19F NMR (565 MHz, CDCl3), δ: –73.74 (d, 3F, 3J(H,F) = 6.2 Hz, CF3); 
HRMS/ESI (m/z) [M+Na]+ calcd for C16H20F3NO3Na, 354.1293, found 354.1293. 
 
cis-N-Benzyl-3-(diethoxymethyl)-2-(trifluoromethyl)azetidin-2-one (cis-4b). 
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Yellow oily β-lactam cis-4b (160 mg, 48% yield, purification on SiO2, using petroleum 
ether/AcOEt = 90:10, more polar fraction); IR (KBr): vmax/cm–1 3033w, 2976vs, 2935s, 
2929w, 2979w, 1779vs (C=O), 1462s, 1387s, 1293vs, 1173vs, 1107vs, 1053vs, 
689s; 1H NMR (600 MHz, CDCl3), δ: 7.39–7.32 (m, 3 CHAr), 7.27–7.26 (m, 2 CHAr), 
4.93 (d, 3J(H,H) = 8.2 Hz, 1H, CH(OEt)2), 4.88, 4.02 (AB system, 2d, 2J(H,H) = 15.1 
Hz, 2H, CH2Ph), 3.90–3.86 (m, 1H, C(4)H), 3.80–3.70 (m, 4H, 2 CH3CH2O), 3.53–
3.48 (m, 1H, C(3)H), 1.29, 1.19 (2t, 3J(H,H) = 7.0 Hz, 6H, 2 CH3CH2O); 13C NMR 
(150 MHz, CDCl3), δ: 165.2 (C=O), 134.6 (1 CAr), 129.0, 128.4, 128.2 (5 CHAr), 124.4 
(q, 1J(C,F) = 277.5 Hz, CF3), 97.9 (brd, 4J(C,F) = 1.4 Hz, CH(OEt)2), 62.8, 62.2 (2 
CH3CH2O), 56.4 (C(3)H), 52.8 (q, 2J(C,F) = 33.9 Hz, C(4)H), 45.6 (CH2Ph), 15.2, 14.8 
(2 CH3CH2O); 19F NMR (565 MHz, CDCl3), δ: –68.80 (d, 3F, 3J(H,F) = 6.0 Hz, CF3). 
HRMS/ESI (m/z) [M+Na]+ calcd for C16H20F3NO3Na, 354.1293, found 354.1295. 
 
trans-N-Benzyl-3-(4-fluorophenyl)-2-(trifluoromethyl)azetidin-2-one (trans-4c). 
Pale yellow solid β-lactam trans-4c (204 mg, 63% yield, purification on SiO2, using 
petroleum ether/AcOEt = 95:5, less polar fraction); m.p. 46–48 ºC; IR (KBr): vmax/cm–1 
3073w, 3029w, 2927w, 2891s, 1766vs (C=O), 1502vs, 1401s, 1313s, 1288s, 1225s, 
1184vs, 1148vs, 1123vs, 950s, 825s, 731s; 1H NMR (600 MHz, CDCl3), δ: 7.42–7.33 
(m, 5 CHAr), 7.23–7.20 (m, 2 CHAr), 7.08–7.04 (m, 2 CHAr), 4.47 (brd, 3J(H,H) = 2.4 
Hz, 1H, C(3)H), 4.99, 4.08 (AB system, 2d, 2J(H,H) = 15.0 Hz, 2H, CH2Ph), 3.78 (dq, 
3J(H,H) = 2.4 Hz, 3J(H,F) = 5.8 Hz, 1H, C(4)H); 13C NMR (150 MHz, CDCl3), δ: 166.2 
(C=O), 162.5 (d, 1J(C,F) = 246.0 Hz, FCAr), 134.6 (1 CAr), 129.1, 129.0, 128.9, 128.5, 
128.3 (7 CHAr), 124.2 (q, 1J(C,F) = 278.3 Hz, CF3), 116.1 (d, 2J(C,F) = 21.6 Hz, 2 
CHAr), 58.0 (q, 2J(C,F) = 33.8 Hz, C(4)H), 55.6 (C(3)H), 48.8 (CH2Ph); 19F NMR (565 
MHz, CDCl3), δ: –73.74 (d, 3J(H,F) = 5.8 Hz, 3F, CF3), –(113.29–113.34) (m, 1F, 
FCAr); HRMS/ESI (m/z) [M+H]+ calcd for C17H14F4NO, 324.1006, found 324.1007. 
 
cis-N-Benzyl-3-(4-fluorophenyl)-2-(trifluoromethyl)azetidin-2-one (cis-4c).  
Pale yellow solid β-lactam cis-4c (87 mg, 27% yield, purification on SiO2, using 
petroleum ether/AcOEt = 90:10, more polar fraction); m.p. 60–63 ºC; IR (KBr): 
vmax/cm–1 3032w, 2934w, 2891s, 1758vs (C=O), 1515s, 1299s, 1159s, 1128s, 819s, 
692s, 532w; 1H NMR (600 MHz, CDCl3), δ: 7.43–7.29 (m, 7 CHAr), 7.08–7.04 (m, 2 
CHAr), 5.01 (d, 2J(H,H) = 15.0 Hz, 1H of AB system from CH2Ph), 4.73 (d, 3J(H,H) = 
6.0 Hz, 1H, C(3)H), 4.12–4.07 (m, 2H, C(4)H, 1H of AB system from CH2Ph); 13C 
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NMR (150 MHz, CDCl3), δ: 166.6 (C=O), 162.6 (d, 1J(C,F) = 246.0 Hz, FCAr), 134.4 
(1 CAr), 130.9 (d, 3J(C,F) = 8.1 Hz, 2 CHAr), 129.1, 128.6, 128.3 (5 CHAr), 126.0 (d, 
4J(C,F) = 3.3 Hz, 1 CAr), 123.8 (q, 1J(C,F) = 278.7 Hz, CF3), 115.6 (d, 2J(C,F) = 21.5 
Hz, 2 CHAr), 56.2 (C(3)H), 55.6 (q, 2J(C,F) = 31.7 Hz, C(4)H), 45.7 (CH2Ph); 19F NMR 
(565 MHz, CDCl3), δ: –68.30 (d, 3J(H,F) = 6.2 Hz, 3F, CF3), –(113.27–113.33) (m, 1F, 
FCAr); HRMS/ESI (m/z) [M+H]+ calcd for C17H14F4NO, 324.1006, found 324.1006. 
 
trans-N-Benzyl-3-methoxycarbonyl-2-(trifluoromethyl)azetidin-2-one (trans-4d). 
Colorless oily β-lactam trans-4d (147 mg, 51% yield, purification on SiO2, using 
petroleum ether/AcOEt = 92:8); IR (film): vmax/cm–1 3052w, 3030w, 3032w, 2942w, 
2921w, 1770vs (C=O), 730s (C=O), 1480s), 1440s, 1397w, 1271s, 1195s, 729s, 
701s; 1H NMR (600 MHz, CDCl3), δ: 7.32–7.27 (m, 2 CHAr), 7.27–7.25 (m, 1 CHAr), 
7.20–7.18 (m, 2 CHAr), 4.12 (dq, 3J(H,H) = 2.1 Hz, 3J(H,F) = 6.1 Hz, 1H, C(4)H), 4.03 
(d, 3J(H,H) = 2.1 Hz, 1H, C(3)H), 4.80, 3.98 (AB system, 2d, 2J(H,H) = 15.2 Hz, 2H, 
CH2Ph), 3.73 (s, 3H, OCH3); 13C NMR (150 MHz, CDCl3), δ: 165.3 (C=O), 160.5 
(CO2Me), 133.7 (1 CAr), 129.0, 128.4, 128.3 (5 CHAr), 123.6 (q, 1J(C,F) = 280.0 Hz, 
CF3), 55.6 (C(3)H), 53.2 (OCH3), 52.9 (q, 2JC,F = 35.1 Hz, C(4)H), 46.1 (CH2Ph); 19F 
NMR (565 MHz, CDCl3), δ: –73.94 (d, 3J(H,F) = 6.1 Hz, 3F, CF3); HRMS/ESI (m/z) 
[M+Na]+ calcd for C13H12F3NO3Na, 310.0662, found 310.0660. 
 
trans-N-Benzyl-3-(tert-butyl)-2-(trifluoromethyl)azetidin-2-one (trans-4e). 
Colorless oily β-lactam trans-4e (129 mg, 45% yield, purification on SiO2, using 
petroleum ether/AcOEt = 95:5, less polar fraction); IR (film): vmax/cm–1 3037w, 2963s, 
2875w, 1770vs (C=O), 1471w, 1383s, 1283s, 1171vs, 1130vs, 696s; 1H NMR (600 
MHz, CDCl3), δ: 7.39–7.34 (m, 3 CHAr), 7.30–7.29 (m, 2 CHAr), 4.93, 3.90 (AB 
system, 2d, 2J(H,H) = 15.0 Hz, 2H, CH2Ph), 3.54 (dq, 3J(H,H) = 2.4 Hz, 3J(H,F) = 6.0 
Hz, 1H, C(4)H), 3.10 (d, 3J(H,H) = 2.4 Hz, 1H, C(3)H), 0.99 (s, 9H, C(CH3)3); 13C 
NMR (150 MHz, CDCl3), δ: 167.5 (C=O), 134.8 (1 CAr), 128.8, 128.7, 128.1 (5 CHAr), 
124.7 (q, 1J(C,F) = 278.0 Hz, CF3), 62.7 (C(3)H), 52.5 (q, 2J(C,F) = 33.6 Hz, C(4)H), 
45.2 (CH2Ph), 31.0 (C(CH3)3), 27.0 (C(CH3)3); 19F NMR (565 MHz, CDCl3), δ: –73.13 
(d, 3J(H,F) = 5.7 Hz, 3F, CF3); HRMS/ESI (m/z) [M+Na]+ calcd for C15H18F3NONa, 
308.1238, found 308.1237. 
 
cis-N-Benzyl-3-(tert-butyl)-2-(trifluoromethyl)azetidin-2-one (cis-4e).  
	   17	  
Colorless oily β-lactam cis-4e (40 mg, 14% yield, purification on SiO2, using 
petroleum ether/AcOEt = 90:10, more polar fraction); IR (film): vmax/cm–1 3033w, 
2961s, 2918s, 2872s, 1765vs (C=O), 1397s, 1281s, 1171vs, 1157vs, 1125vs, 694s; 
1H NMR (600 MHz, CDCl3), δ: 7.39–7.32 (m, 3 CHAr), 7.27–7.26 (m, 2 CHAr), 4.91, 
3.96 (AB system, 2d, 2JH,H = 15.0 Hz, 2H, CH2Ph), 3.84, 3.83 (2dq, 3J(H,H) = 7.9 Hz, 
3J(H,F) = 18.0 Hz, 1H, C(4)H), 3.34 (d, 3J(H,H) = 7.9 Hz, 1H, C(3)H), 1.16 (s, 9H, 
C(CH3)3); 13C NMR (150 MHz, CDCl3), δ: 168.5 (C=O), 134.9 (1 CAr), 128.9, 128.5, 
128.0 (5 CHAr), 124.8 (q, 1J(C,F) = 277.8 Hz, CF3), 65.4 (C(3)H), 52.2 (q, 2J(C,F) = 
34.8 Hz, C(4)H), 45.2 (CH2Ph), 31.5 (C(CH3)3), 28.4 (q, J(C,F) = 2.2 Hz, C(CH3)3); 
19F NMR (565 MHz, CDCl3), δ: –65.38 (d, 3J(H,F) = 7.9 Hz, 3F, CF3); HRMS/ESI 
(m/z) [M+Na]+ calcd for C15H18F3NONa, 308.1238, found 308.1235. 
 
trans-N-Benzyl-3-ferrocenyl-2-(trifluoromethyl)azetidin-2-one (trans-4f).  
Orange solid β-lactam trans-4f (290 mg, 70% yield), purification on SiO2, using 
petroleum ether/AcOEt = 90:10); m.p. 101–103 ºC; IR (KBr): vmax/cm–1 3084w, 
3028w, 2922w, 1747vs (C=O), 1405m, 1297m, 1191s, 1148s, 1127s, 694w; 1H NMR 
(600 MHz, CDCl3), δ: 7.42–7.39 (m, 2 CHAr), 7.37–7.34 (m, 3 CHAr), 4.92, 4.08 (AB 
system, 2d, 2J(H,H) = 15.0 Hz, 2H, CH2Ph), 4.21-4.19 (m, 1H, C(3)H), 4.18 (brs, 7H, 
Fc), 4.11, 4.07 (2 brs, 2H, Fc), 3.73 (dq, 3J(H,H) = 2.9 Hz, 3J(H,F) = 7.2 Hz, 1H, 
C(4)H); 13C NMR (150 MHz, CDCl3), δ: 166.1 (C=O), 134.8 (1 CAr), 129.0, 128.6, 
128.3 (5 CHAr), 124.4 (q, 1J(C,F) = 278.3 Hz, CF3), 69.0 (5 CH(Fc)), 79.7 (C(Fc)), 
68.5, 68.4, 67.1, 66.7 (4 CH(Fc)), 58.2 (q, 2J(C,F) = 36.2 Hz, C(4)H), 52.3 (brq, 
3J(C,F) = 1.3 Hz, C(3)H), 45.6 (CH2Ph); 19F NMR (565 MHz, CDCl3), δ: –73.49 (d, 
3J(H,F) = 5.9Hz, 3F, CF3); HRMS/ESI (m/z) [M+Na]+ calcd for C21H18F3NONaFe, 
436.0588, found  436.0586. 
 
trans-N-Benzyl-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-(trifluoromethyl)azetidin-
2-one ((R)-trans-4g).  
Pale yellow solid β-lactam (R)-trans-4g (156 mg, 48% yield, purification on SiO2, 
using petroleum ether/AcOEt = 96:4, less polar fraction); m.p. 49–51 ºC; [α]D22 = –
55.6 (c 1.0 in DCM); IR (KBr): vmax/cm–1 2994w, 2929w, 1754vs (C=O), 1455w, 1383s, 
1293s, 1166vs, 1125vs, 1071s, 832w, 697s; 1H NMR (600 MHz, CDCl3), δ: 7.39–
7.33 (m, 5 CHAr), 4.95, 3.99 (AB system, 2d, 2JH,H = 12.0 Hz, 2H, CH2Ph), 4.35 (dt, 
3J(H,H) = 3.0 Hz, 4J(H,H) = 1.0 Hz, 1H, CHOC(CH3)2), 4.11–4.06 (m, 2H, 
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CH2OC(CH3)2), 3.93 (dq, 3J(H,H) = 1.8 Hz, 3J(H,F) = 6.0 Hz, 1H, C(4)H), 3.50–3.48 
(m, 1H, C(3)H), 1.44, 1.37 (2s, 6H, 2 CH3); 13C NMR (150 MHz, CDCl3), δ: 165.3 
(C=O), 134.4 (1 CAr), 128.8, 128.5, 128.1 (5 CHAr), 124.4 (q, 2J(C,F) = 277.5 Hz, CF3), 
110.1 ((CH3)2CO2), 71.9 (CH2OC(CH3)2)), 66.1 (CHOC(CH3)2), 53.3 (brd, C(3)H), 
53.3 (brs, CH2OC(CH3)2), 53.0 (q, 2J(C,F) = 34.4 Hz, C(4)H), 45.6 (CH2Ph), 25.7, 
26.2 (2 CH3); 19F NMR (565 MHz, CDCl3), δ: –68.80 (d, 3J(H,F) = 7.2 Hz, 3F, CF3); 
HRMS/ESI (m/z) [M+Na]+ calcd for C16H18F3NO3Na, 352.1136, found 352.1134. 
 
cis-N-Benzyl-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-(trifluoromethyl)azetidin-2-
one ((R)-cis-4g and (R)-cis-4g’).  
Pale yellow semi-solid β-lactams (R)-cis-4g and (R)-cis-4g’ (85:15 mixture of 
diastereoisomers; 111 mg, 34% yield, purification on SiO2, using petroleum 
ether/AcOEt = 92:8, more polar fraction); m.p. 48–49 ºC; [α]D22 = –69.5 (c 1.0 in 
DCM); IR (KBr): vmax/cm–1 2987s, 2936w, 2890w, 1774vs (C=O), 1460s, 1367s, 
1286vs, 1191vs, 1139vs, 1055vs, 848s, 711s, 692s; 1H NMR (600 MHz, CDCl3), δ: 
Major diastereoisomer: 4.90, 4.02 (AB system, 2d, 2J(H,H) = 12.0 Hz, 2H, CH2Ph), 
3.93 (dq, 3J(H,F) = 6.0 Hz, 3J(H,H) = 2.2 Hz, 1H, C(4)H), Minor diastereoisomer : 
4.94 (d, 2J(H,H) = 12.0 Hz, 1H of AB system from CH2Ph), 3.90–3.86 (m, 1H, C(4)H), 
Both diastereoisomers: 7.40–7.31 (m, 5 CHAr), 3.80–3.70 (m, 4H, 1H of AB system 
from CH2Ph (minor isomer), 2H, CH2OC(CH3)2), 1H, CHOC(CH3)2), 1.29, 1.19 (2s, 
6H, 2 CH3); 13C NMR (150 MHz, CDCl3), δ: Major diastereoisomer: 165.2 (C=O), 
134.6 (1 CAr) 129.0, 128.4, 128.2 (5 CHAr), 124.4 (q, 2J(C,F) = 278.6 Hz, CF3), 110.1 
(CH3)2CO2), 71.9 (CH2OC(CH3)2), 66.1 (CHOC(CH3)2), 56.4 (C(3)H), 52.9 (q, 2J(C,F) 
= 33.8 Hz, C(4)H), 45.6 (CH2Ph), 14.8, 15.2 (2 CH3), Minor diastereoisomer: 167.1 
(C=O), 134.0 (1 CAr), 128.9, 128.4, 128.2 (5 CHAr), 124.3 (q, 2J(C,F) = 278.0 Hz, 
CF3), 67.2 (CH2OC(CH3)2)), 64.0 (CHOC(CH3)2), 56.4 (C(3)H), 52.2 (q, 2J(C,F) = 34.7 
Hz, C(4)H), 46.0 (CH2Ph), (CH3)2C and (CH3)2C) not found; 19F NMR (565 MHz, 
CDCl3), δ: Major diastereoisomer: –68.80 (d, 3J(H,F) = 6.2 Hz, 3F, CF3), Minor 
diastereoisomer: –73.78 (d, 3J(H,F) = 6.0 Hz, 3F, CF3); HRMS/ESI (m/z) [M+Na]+ 
calcd for C16H18F3NO3Na, 352.1136, found 352.1136. 
 
trans-N-(S)-Methylbenzyl-3-phenyl-2-(trifluoromethyl)azetidin-2-one ((S)-trans-
4h). 
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Colorless semi-solid β-lactam (S)-trans-4h (51 mg, 16% yield, purification on SiO2, 
using petroleum ether/AcOEt = 97:3, least polar fraction); m.p. 70–71 ºC; [α]D22 = –
23.2 (c 1.0 in DCM); IR (KBr): vmax/cm–1 3026w, 2980w, 2933w, 1747vs (C=O), 
1493w, 1358w, 1276s, 1195s, 1172s, 700s; 1H NMR (600 MHz, CDCl3), δ: 7.41–7.32 
(m, 8 CHAr), 7.24–7.23 (m, 2 CHAr), 4.61 (q, 3J(H,H) = 7.2 Hz, 1H, CH3CH(Ph)), 4.39 
(brs, 1H, C(3)H), 3.80 (dq, 3J(H,H) = 2.4 Hz, 3J(H,F) = 6.1 Hz, 1H, C(4)H), 1.91 (d, 
3J(H,H) = 7.2 Hz, 3H, CH3CH(Ph)); 13C NMR (150 MHz, CDCl3), δ: 166.5 (C=O), 
140.7, 132.9 (2 CAr), 129.1, 128.9, 128.2, 128.1, 127.3, 126.7 (10 CHAr), 124.3 (q, 
1J(C,F) = 278.3 Hz, CF3), 57.7 (q, 2J(C,F) = 33.6 Hz, C(4)H), 56.1 (CH3CH(Ph)), 55.5 
(C(3)H), 19.8 (CH3CH(Ph)); 19F NMR (565 MHz, CDCl3), δ: –73.97 (d, 3J(H,F) = 6.1 
Hz, 3F, CF3); HRMS/ESI (m/z) [M+Na]+ calcd for C18H16F3NONa, 342.1073, found 
342.1072.  
 
trans-N-(S)-Methylbenzyl-3-phenyl-2-(trifluoromethyl)azetidine-2-one ((S)-trans-
4h’).  
Colorless semi-solid β-lactam (S)-trans-4h’ (122 mg, 38% yield, purification on SiO2, 
using petroleum ether/AcOEt = 95:5, medium polar fraction); m.p. 71–72 ºC; [α]D22 = 
–30.8 (c 1.0 in DCM); IR (KBr): vmax/cm–1 3032w, 2983w, 2931w, 1747vs (C=O), 
1457s, 1345s, 1285s, 1198s, 1168s, 1130vs, 700vs; 1H NMR (600 MHz, CDCl3), δ: 
7.42–7.41 (m, 4 CHAr), 7.37–7.31 (m, 4 CHAr), 7.20–7.19 (m, 2 CHAr), 5.21 (q, 3J(H,H) 
= 7.0 Hz, 1H, CH3CH(Ph)), 4.38 (d, 3J(H,H) = 2.4 Hz, 1H, C(3)H), 3.72 (dq, 3J(H,H) = 
2.4 Hz, 3J(H,F) = 6.0 Hz, 1H, C(4)H), 1.71 (d, 3J(H,H) = 7.0 Hz, 3H, CH3CH(Ph)); 13C 
NMR (150 MHz, CDCl3), δ: 166.6 (C=O), 138.6, 132.8 (2 CAr), 129.1, 128.9, 128.2, 
128.1, 127.3, 127.2 (10 CHAr), 124.3 (q, 1J(C,F) = 277.7 Hz, CF3), 58.1 (q, 2J(C,F) = 
34.2 Hz, C(4)H), 55.8 (C(3)H), 52.2 (CH3CH(Ph)), 17.9 (CH3CH(Ph)); 19F NMR (565 
MHz, CDCl3), δ: –73.70 (d, 3J(H,F) = 6.2 Hz, 3F, CF3); HRMS/ESI (m/z) [M+Na]+ 
calcd for C18H16F3NONa, 342.1073, found 342.1074. 
 
cis-N-(S)-Methylbenzyl-3-phenyl-2-(trifluoromethyl)azetidin-2-one ((S)-cis-4h). 
Colorless solid β-lactam (S)-cis-4h (21 mg, 7% yield, purification on SiO2, using 
petroleum ether/AcOEt = 92:8, most polar fraction); m.p. 71–73 ºC; [α]D = –26.9 (c 
1.0 in DCM); IR (KBr): vmax/cm–1 3066w, 3030w, 2928w, 1750vs (C=O), 1450m, 
1360m, 1290s, 1186s, 1141vs, 1105s, 710s; 1H NMR (600 MHz, CDCl3), δ: 7.34–
7.30 (m, 5 CHAr), 7.27–7.22 (m, 3 CHAr), 7.21–7.18 (m, 2 CHAr), 5.15 (q, 3J(H,H) = 
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7.2 Hz, 1H, CH3CH(Ph)), 4.55 (d, 3J(H,H) = 6.0 Hz, 1H, C(3)H), 3.90–3.86 (m, 1H, 
C(4)H), 1.60 (d, 3J(H,H) = 7.2 Hz, 3H, CH3CH(Ph)); 13C NMR (150 MHz, CDCl3), δ: 
167.0 (C=O), 138.4, 130.3 (2 CAr), 129.4, 128.9, 128.5, 128.3, 128.2, 127.3 (10 
CHAr), 123.6 (q, 1J(C,F) = 278.3 Hz, CF3), 56.6 (C(3)H), 55.8 (q, 2J(C,F) = 33.0 Hz, 
C(4)H), 52.0 (CH3CH(Ph)), 18.0 (CH3CH(Ph)); 19F NMR (565 MHz, CDCl3), δ: –68.47 
(d, 3J(H,F) = 6.8 Hz, 3F, CF3); HRMS/ESI (m/z) [M+Na]+ calcd for C18H16F3NONa, 
342.1078, found 342.1073. 
 
trans/cis-N-Benzyl-2-difluoromethyl-3-phenylazetidin-2-one (trans/cis-4i).  
Colorless oily β-lactams trans/cis-4i (70:30 mixture of diastereoisomers; 267 mg, 
93% yield, purification on SiO2, using petroleum ether/AcOEt = 94:6); IR (film): 
vmax/cm-1 3087w, 3064w, 3026s, 2937w, 1767vs (C=O), 1602w, 1493s, 1446s, 
1387s, 1075s, 691s; 1H NMR (600 MHz, CDCl3), δ: Major diastereoisomer: 5.40 
(ddd, 2J(H,F(1)) = 60.1 Hz, 2J(H,F(2)) = 56.1 Hz, 3J(H,H) = 6.4 Hz, 1H, CHF2), 4.93, 
4.17 (AB system, 2d, 2J(H,H) = 14.8 Hz, 2H, CH2Ph), 4.65 (d, 3J(H,H) = 5.8 Hz, 1H, 
C(3)H), 3.91–3.87 (m, 1H, C(4)H); Minor diastereoisomer: 5.91 (td, 2J(H,F) = 55.0 Hz, 
3J(H,H) = 4.2 Hz, 1H, CHF2), 4.85, 4.24 (AB system, 2d, 2J(H,H) = 15.0 Hz, 2H, 
CH2Ph), 4.36 (d, 3J(H,H) = 2.0 Hz, 1H, C(3)H), 3.74–3.70 (m, 1H, C(4)H); Both 
diastereoisomers: 7.43–7.29 (m, 18 CHAr), 7.26–7.25 (m, 2 CHAr); 13C NMR (150 
MHz, CDCl3), δ: 166.9 (C=O), 167.0 (C=O), 135.3, 135.2, 133.4, 130.8 (4 CAr), 129.1, 
129.0, 128.9, 128.8, 128.7, 128.6, 128.3, 128.2, 128.1, 128.0 (20 CHAr), 115.5 (t, 
2J(C,F) = 21.1 Hz, CHF2), 115.0 (t, 2J(C,F) = 21.1 Hz, CHF2), 55.6 (t-like, 2J(C,F) = 
12.0 Hz, C(4)H), 55.4 (dd, 2J(C,F(1)) = 30.0 Hz, 2J(C,F(2)) = 20.1 Hz, C(4)H), 46.0, 
45.9 (2brs, 2 CH2Ph); 19F NMR (565 MHz, CDCl3), δ: –123.62, –123.71 (2t, J = 7.7 
Hz, CHF2 (Major diastereoisomer)), –120.20, –123.54 (2ddd, 2J(F,F) = 304.5 Hz, 
2J(H,F) = 53.8 Hz, 3J(H,F) = 6.4 Hz, CHF2 (Minor diastereoisomer)); HRMS/ESI (m/z) 
[M+Na]+ calcd for C17H15F2NONa, 310.1011, found 310.1019. 
 
trans/cis-N-(S)-methylbenzyl-2-(Difluoromethyl)-3-phenylazetidin-2-one 
(trans/cis-4j). 
Colorless solid β-lactams trans/cis-4j (73:18:9 inseparable mixture of 
diastereoisomers A, B, and C; 169 mg, 58% yield, purification on SiO2, using 
petroleum ether/AcOEt = 92:8); m.p. 73–76 ºC; [α]D = –26.9 (c 1.0 in DCM). IR (KBr): 
vmax/cm–1 3065w, 3035w, 2988w, 2938w, 1738vs (C=O), 1495s, 145s, 1349s, 1161s, 
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1131vs, 1054vs, 756s, 695vs; 1H NMR (600MHz, CDCl3), δ: Diastereoisomer A 
(73%): 5.83 (dt, 2J(H,F) = 55.0 Hz, 3J(H,H) = 3.8 Hz, 1H, CHF2), 5.12 (q, 3J(H,H) = 7.2 
Hz, 1H, CH3CH(Ph)), 4.30 (d, 3J(H,H) = 2.3 Hz, 1H, C(3)H), 3.63–3.59 (m, 1H, 
C(4)H), 1.73 (d, 3H, 3J(H,H) = 7.2 Hz, CH3CH(Ph)); Diastereoisomer B (18%): 5.66 
(dt, 2J(H,F) = 55.2 Hz, 3J(H,H) = 3.8 Hz, 1H, CHF2), 4.83 (q, 3J(H,H) = 7.2 Hz, 1H, 
CH3CH(Ph)), 4.31 (d, 3J(H,H) = 2.4 Hz, 1H, C(3)H), 3.73–3.69 (m, 1H, C(4)H), 1.85 
(d, 3H, 3J(H,H) = 7.2 Hz, CH3CH(Ph)); Diastereoisomer C (9%): 5.62–5.57 (m, 1H, 
CHF2), 4.70 (q, 3J(H,H) = 7.2 Hz, 1H, CH3CH(Ph)), 4.58 (t-like, 3J(H,H) and 4J(H,H) = 
5.6 Hz, 1H, C(3)H), 3.90–3.80 (m, 1H, C(4)H), 1.92 (d, 3H, 3J(H,H) = 7.3 Hz, 
CH3CHPh); All three diastereoisomers: 7.22–7.20 (m, 6 CHAr), 7.44–7.27 (m, 24 
CHAr); 13C NMR (150 MHz, CDCl3), δ: 167.1, 167.0, 166.9 (3 C=O), 139.4, 133.6 
(CAr), 129.0, 128.9, 128.2, 127.9, 127.4, 127.2, 126.9, 126.8 (30 CHAr), 115.0, 114.6, 
114.5 (3 t, 2J(C,F) = 241.5 Hz, CHF2), 59.3, 58.6, 54.7 (3t-like, 3J(H,H) = 26.3 Hz, 
C(4)H), 54.3, 52.7, 52.5 (CH3CH(Ph)), 19.3, 19.1, 18.8 ppm (3 CH3); 19F {1H} NMR 
(188 MHz, CDCl3), δ: –125.0, –123.2 (AB system, 2J(F,F) = 292.8 Hz 
(Diastereoisomer A)), –125.2, –123.5 (AB system, 2J(F,F) = 294.2 Hz 
(Diastereoisomer B)), –122.8, –120.7 (AB system, 2J(F,F) = 302.6 Hz 
(Diastereoisomer C)); HRMS/ESI (m/z) [M+Na]+ calcd for C18H17F2NONa, 302.1353, 
found 302.1351. 
 
X-Ray Crystal Structure Determination of 4a. All measurements were made on an 
Agilent Technologies SuperNova area-detector diffractometer20 using CuKα radiation 
(λ = 1.54184 Å) from a micro-focus X-ray source and an Oxford Instruments Cryojet 
XL cooler. The data collection and refinement parameters are given below21 and a 
view of the molecule is shown in Fig. 2. Data reduction was performed with 
CrysAlisPro.20 The intensities were corrected for Lorentz and polarization effects, and 
an empirical absorption correction using spherical harmonics20 was applied. 
Equivalent reflections, other than Friedel pairs, were merged. The structure was 
solved by direct methods using SHELXS-2014,22 which revealed the positions of all 
non-hydrogen atoms. The non-hydrogen atoms were refined anisotropically. All of the 
H-atoms were placed in geometrically calculated positions and refined by using a 
riding model where each H-atom was assigned a fixed isotropic displacement 
parameter with a value equal to 1.2Ueq of its parent C-atom. The refinement of the 
structure was carried out on F2 by using full-matrix least-squares procedures, which 
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minimized the function Σw(Fo2 – Fc2)2. A correction for secondary extinction was not 
applied. The structure was refined as an inversion twin, but the precision of the 
absolute structure parameter,23 0.44(16), is too low for this parameter to be a 
sufficient indicator of the true absolute structure. Neutral atom scattering factors for 
non-H-atoms were taken from ref.24, and the scattering factors for H-atoms were 
taken from ref.25 Anomalous dispersion effects were included in Fc;26 the values for f' 
and f" were those of ref.27 The values of the mass attenuation coefficients are those 
of ref.28 All calculations were performed using the SHELXL-201429 program. 
Crystal data for 4a: C17H14F3NO, M = 305.29, crystallized from diisopropyl 
ether/n-heptane, colorless, prism, crystal dimensions 0.15 × 0.16 × 0.30 mm, 
monoclinic, space group P21, Z = 2, reflections for cell determination 5244, 2θ range 
for cell determination 7 – 152°, a = 11.9664(4) Å, b = 5.54706(14) Å, c = 12.4674(5) 
Å, β = 115.633(4), V = 746.12(5) Å3, T = 160(1) K, DX = 1.359 g⋅cm–3, µ(CuKα) = 
0.940 mm–1, scan type ω, 2θ(max) = 153.1°, transmission factors (min; max) = 0.519; 
1.000, total reflections measured 8153, symmetry independent reflections 2954, 
reflections with I > 2σ(I) 2817, reflections used in refinement 2954, parameters 
refined 200, restraints 1, R(F) [I > 2σ(I) reflections] = 0.0301, wR(F2) [all data] = 
0.0822 (w = [σ2(Fo2)+ (0.0456P)2+0.0903P]–1, where P = (Fo2+2Fc2)/3), goodness of 
fit 1.034, final Δmax/σ 0.000, Δρ (max; min) = 0.12; –0.14 e Å–3. 
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